FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897156727> ?p ?o ?g. }

• W2897156727 endingPage "318" @default.
• W2897156727 startingPage "303" @default.
• W2897156727 abstract "Schizophrenia is the eighth leading cause of disability worldwide in people aged 15–44 years. Before antidopaminergic antipsychotics were introduced in the 1950s, no effective medications existed for the treatment of schizophrenia. This review summarizes key meta-analytic findings regarding antipsychotic efficacy in the acute treatment of schizophrenia, including clozapine in treatment-resistant patients. In the most comprehensive meta-analysis of randomized controlled trials conducted in multi-episode schizophrenia, antipsychotics outperformed placebo regarding total symptoms, positive symptoms, negative symptoms, depressive symptoms, quality of life and social functioning. Amongst these outcomes, the standardized mean difference for overall symptoms was largest, that is, 0.47 (95% credible interval = 0.42–0.51), approaching a medium effect size, being reduced to 0.38 when publication bias and small-trial effects were accounted for. A comparison of two meta-analyses indicated that first-episode patients, compared with multi-episode patients, were more likely to have at least minimal treatment response [⩾20% Positive and Negative Syndrome Scale (PANSS)/Brief Psychiatric Rating Scale (BPRS) score reduction: 81% versus 51%] and good response (⩾50% PANSS/BPRS score reduction: 52% versus 23%). In multi-episode schizophrenia, no response or worsening after 2 weeks of a therapeutic antipsychotic dose was highly predictive of not achieving a good response at endpoint (median treatment = 6 weeks: specificity = 86%; positive predictive value = 90%), suggesting a change in treatment should be considered in such cases. In first-episode psychosis, adequately dosed antipsychotic treatment trials for more than 2 weeks are recommended before using no response or worsening as a decision point for aborting a given antipsychotic. In clearly defined treatment-resistant schizophrenia, clozapine generally outperformed other antipsychotics, especially when dosed appropriately (target = 3–6 months’ duration; trough clozapine level ⩾350–400 μg/L) with a response rate (⩾20% PANSS/BPRS) of 33% by 3 months of treatment. High antipsychotic doses and psychotropic combinations are unlikely to be superior to standard doses of antipsychotic monotherapy. Acute antipsychotic efficacy in schizophrenia depends on the targeted symptom domain (greater efficacy: total and positive symptoms, lesser efficacy: negative symptoms, depressive symptoms, social functioning and quality of life). Greater antipsychotic efficacy is associated with higher total baseline symptom severity, treatment-naïveté/first-episode status, shorter illness duration, and trials that are nonindustry sponsored and that have a lower placebo effect. The heterogeneity of antipsychotic response across individuals and key symptom domains, the considerable degree of nonresponse/treatment resistance in multi-episode patients, and the adverse effect potential of antipsychotics are major limitations, underscoring the need to develop new medications for the treatment of schizophrenia. Drug development should include matching patient subgroups, which are identified by means of clinical and biomarker variables, to mechanisms of action of novel medications, targeting specific symptom domains, and investigating mechanisms of action other than dopaminergic blockade." @default.
• W2897156727 created "2018-10-26" @default.
• W2897156727 creator A5050643863 @default.
• W2897156727 creator A5056944189 @default.
• W2897156727 date "2018-10-08" @default.
• W2897156727 modified "2023-10-11" @default.
• W2897156727 title "The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses" @default.
• W2897156727 cites W135360890 @default.
• W2897156727 cites W1565231669 @default.
• W2897156727 cites W1969060266 @default.
• W2897156727 cites W1980862554 @default.
• W2897156727 cites W1981639809 @default.
• W2897156727 cites W1984250632 @default.
• W2897156727 cites W1986011584 @default.
• W2897156727 cites W1995582028 @default.
• W2897156727 cites W1996858839 @default.
• W2897156727 cites W1998873927 @default.
• W2897156727 cites W2000636120 @default.
• W2897156727 cites W2003154946 @default.
• W2897156727 cites W2008169351 @default.
• W2897156727 cites W2008803238 @default.
• W2897156727 cites W2009832071 @default.
• W2897156727 cites W2011675347 @default.
• W2897156727 cites W2013615650 @default.
• W2897156727 cites W2015482098 @default.
• W2897156727 cites W201840336 @default.
• W2897156727 cites W2022787364 @default.
• W2897156727 cites W2029880466 @default.
• W2897156727 cites W2038946755 @default.
• W2897156727 cites W2063014429 @default.
• W2897156727 cites W2067865118 @default.
• W2897156727 cites W2074863161 @default.
• W2897156727 cites W2078394222 @default.
• W2897156727 cites W2083764460 @default.
• W2897156727 cites W2085360366 @default.
• W2897156727 cites W2092173202 @default.
• W2897156727 cites W2113463828 @default.
• W2897156727 cites W2116594433 @default.
• W2897156727 cites W2123069664 @default.
• W2897156727 cites W2125249259 @default.
• W2897156727 cites W2131019553 @default.
• W2897156727 cites W2133339410 @default.
• W2897156727 cites W2133602373 @default.
• W2897156727 cites W2134721961 @default.
• W2897156727 cites W2135689380 @default.
• W2897156727 cites W2138231636 @default.
• W2897156727 cites W2142820908 @default.
• W2897156727 cites W2146069113 @default.
• W2897156727 cites W2151330137 @default.
• W2897156727 cites W2157007129 @default.
• W2897156727 cites W2160135912 @default.
• W2897156727 cites W2160738158 @default.
• W2897156727 cites W2161368430 @default.
• W2897156727 cites W2162176367 @default.
• W2897156727 cites W2165731251 @default.
• W2897156727 cites W2165988750 @default.
• W2897156727 cites W2168985903 @default.
• W2897156727 cites W2258649766 @default.
• W2897156727 cites W2270975510 @default.
• W2897156727 cites W2273674479 @default.
• W2897156727 cites W2285143506 @default.
• W2897156727 cites W2335619680 @default.
• W2897156727 cites W2405203525 @default.
• W2897156727 cites W2461169273 @default.
• W2897156727 cites W2560754155 @default.
• W2897156727 cites W2605936348 @default.
• W2897156727 cites W2607762772 @default.
• W2897156727 cites W2616114255 @default.
• W2897156727 cites W2620112462 @default.
• W2897156727 cites W2623053349 @default.
• W2897156727 cites W2724680974 @default.
• W2897156727 cites W2729856336 @default.
• W2897156727 cites W2737489340 @default.
• W2897156727 cites W2740094929 @default.
• W2897156727 cites W4211025465 @default.
• W2897156727 cites W4248000293 @default.
• W2897156727 cites W4250337222 @default.
• W2897156727 cites W4253924106 @default.
• W2897156727 cites W940697911 @default.
• W2897156727 doi "https://doi.org/10.1177/2045125318781475" @default.
• W2897156727 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6180374" @default.
• W2897156727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30344997" @default.
• W2897156727 hasPublicationYear "2018" @default.
• W2897156727 type Work @default.
• W2897156727 sameAs 2897156727 @default.
• W2897156727 citedByCount "113" @default.
• W2897156727 countsByYear W28971567272019 @default.
• W2897156727 countsByYear W28971567272020 @default.
• W2897156727 countsByYear W28971567272021 @default.
• W2897156727 countsByYear W28971567272022 @default.
• W2897156727 countsByYear W28971567272023 @default.
• W2897156727 crossrefType "journal-article" @default.
• W2897156727 hasAuthorship W2897156727A5050643863 @default.
• W2897156727 hasAuthorship W2897156727A5056944189 @default.
• W2897156727 hasBestOaLocation W28971567271 @default.
• W2897156727 hasConcept C118552586 @default.
• W2897156727 hasConcept C126322002 @default.
• W2897156727 hasConcept C142724271 @default.

• next